Calcium, Vitamin D3 & Bone Health

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Thiamine Hydrochloride Tablets (100mg) is an oral Vitamin B1 preparation on the WHO Model List of Essential Medicines for prevention and treatment of thiamine deficiency, dry and wet beriberi, and nutritional support in chronic alcoholism.

Calcitriol Capsules (0.25mcg; alone or in bone complexes with Calcium, Vitamin K2-7, Zinc) is the biologically active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol) on the WHO Model List of Essential Medicines. Unlike cholecalciferol, it requires no metabolic activation by the liver or kidneys, directly activating intestinal calcium absorption and bone remodeling. Indicated for management of hypocalcemia and renal osteodystrophy in patients with chronic kidney disease, hypoparathyroidism, pseudohypoparathyroidism, and severe osteoporosis.

Cholecalciferol (Vitamin D3 60,000 IU Softgels, Chewable Tablets, Granules Sachet, Oral Solution, and Orally Disintegrating Strips) is a high-dose therapeutic vitamin D3 replenishment therapy on the WHO Model List of Essential Medicines. In the liver, it is converted to 25-hydroxyvitamin D3 (calcifediol), then in the kidneys to active 1,25-dihydroxyvitamin D3 (calcitriol). Calcitriol activates the nuclear Vitamin D Receptor (VDR), powerfully increasing intestinal absorption of dietary calcium and phosphorus by >30-40%, suppressing parathyroid hormone (PTH) secretion, and promoting bone mineralization. Indicated for treatment and prevention of clinical vitamin D deficiency, nutritional rickets, osteomalacia, postmenopausal osteoporosis, and secondary hyperparathyroidism.

Calcitriol Capsules (0.25mcg; alone or in bone complexes with Calcium, Vitamin K2-7, Zinc) is the biologically active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol) on the WHO Model List of Essential Medicines. Unlike cholecalciferol, it requires no metabolic activation by the liver or kidneys, directly activating intestinal calcium absorption and bone remodeling. Indicated for management of hypocalcemia and renal osteodystrophy in patients with chronic kidney disease, hypoparathyroidism, pseudohypoparathyroidism, and severe osteoporosis.

Calcium Formulations (Calcium Carbonate 500mg/1250mg, Calcium Citrate Malate 250mg/1000mg, Coral Calcium with Vitamin D3 250-2000 IU, Vitamin K2-7, Magnesium, and Zinc) is an oral bone remineralization complex on the WHO Model List of Essential Medicines. Calcium provides elemental bone mineral matrix; vitamin D3 stimulates intestinal calcium transport; vitamin K2-7 (menaquinone-7) activates osteocalcin to bind calcium into hydroxyapatite crystals while preventing ectopic arterial vascular calcification; zinc and magnesium act as essential osteoblast cofactors. Indicated for prevention and treatment of postmenopausal osteoporosis, osteopenia, pregnancy/lactation calcium demands, and bone fracture healing.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Calcium Acetate Tablets (667mg, providing 169mg elemental calcium) is an oral intestinal phosphate binder on the WHO Model List framework. In the acidic stomach and duodenum, calcium acetate binds dietary phosphorus to form insoluble calcium phosphate complexes that are excreted in feces, preventing phosphate absorption without excessive calcium absorption. Indicated for control of hyperphosphatemia in adult and pediatric patients with End-Stage Renal Disease (ESRD) / Chronic Kidney Disease on hemodialysis.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Calcium Gluconate Injection IP (10% w/v ampoule / 1g in 10ml, delivering 93 mg elemental calcium) is a sterile parenteral calcium replenishment agent on the WHO Model List of Essential Medicines. It raises extracellular calcium concentrations, stabilizing cardiac myocyte membrane potential against hyperkalemia and reversing hypocalcemic tetany. Indicated for emergency treatment of acute severe hypocalcemia (tetany, carpopedal spasm), cardioprotection in severe hyperkalemia, and magnesium sulfate toxicity reversal.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Calcitriol Capsules (0.25mcg; alone or in bone complexes with Calcium, Vitamin K2-7, Zinc) is the biologically active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol) on the WHO Model List of Essential Medicines. Unlike cholecalciferol, it requires no metabolic activation by the liver or kidneys, directly activating intestinal calcium absorption and bone remodeling. Indicated for management of hypocalcemia and renal osteodystrophy in patients with chronic kidney disease, hypoparathyroidism, pseudohypoparathyroidism, and severe osteoporosis.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Calcitriol Capsules (0.25mcg; alone or in bone complexes with Calcium, Vitamin K2-7, Zinc) is the biologically active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol) on the WHO Model List of Essential Medicines. Unlike cholecalciferol, it requires no metabolic activation by the liver or kidneys, directly activating intestinal calcium absorption and bone remodeling. Indicated for management of hypocalcemia and renal osteodystrophy in patients with chronic kidney disease, hypoparathyroidism, pseudohypoparathyroidism, and severe osteoporosis.

Calcium Formulations (Calcium Carbonate 500mg/1250mg, Calcium Citrate Malate 250mg/1000mg, Coral Calcium with Vitamin D3 250-2000 IU, Vitamin K2-7, Magnesium, and Zinc) is an oral bone remineralization complex on the WHO Model List of Essential Medicines. Calcium provides elemental bone mineral matrix; vitamin D3 stimulates intestinal calcium transport; vitamin K2-7 (menaquinone-7) activates osteocalcin to bind calcium into hydroxyapatite crystals while preventing ectopic arterial vascular calcification; zinc and magnesium act as essential osteoblast cofactors. Indicated for prevention and treatment of postmenopausal osteoporosis, osteopenia, pregnancy/lactation calcium demands, and bone fracture healing.

Calcitriol Capsules (0.25mcg; alone or in bone complexes with Calcium, Vitamin K2-7, Zinc) is the biologically active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol) on the WHO Model List of Essential Medicines. Unlike cholecalciferol, it requires no metabolic activation by the liver or kidneys, directly activating intestinal calcium absorption and bone remodeling. Indicated for management of hypocalcemia and renal osteodystrophy in patients with chronic kidney disease, hypoparathyroidism, pseudohypoparathyroidism, and severe osteoporosis.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Cholecalciferol (Vitamin D3 60,000 IU Softgels, Chewable Tablets, Granules Sachet, Oral Solution, and Orally Disintegrating Strips) is a high-dose therapeutic vitamin D3 replenishment therapy on the WHO Model List of Essential Medicines. In the liver, it is converted to 25-hydroxyvitamin D3 (calcifediol), then in the kidneys to active 1,25-dihydroxyvitamin D3 (calcitriol). Calcitriol activates the nuclear Vitamin D Receptor (VDR), powerfully increasing intestinal absorption of dietary calcium and phosphorus by >30-40%, suppressing parathyroid hormone (PTH) secretion, and promoting bone mineralization. Indicated for treatment and prevention of clinical vitamin D deficiency, nutritional rickets, osteomalacia, postmenopausal osteoporosis, and secondary hyperparathyroidism.

Calcium Polystyrene Sulphonate Powder (15g sachet) is a cation-exchange resin on the WHO Model List framework for hyperkalemia. In the gastrointestinal tract (predominantly the colon), it releases calcium ions in exchange for potassium ions, binding potassium which is excreted in the feces. Indicated for treatment of hyperkalemia associated with acute and chronic kidney disease.

Cholecalciferol (Vitamin D3 60,000 IU Softgels, Chewable Tablets, Granules Sachet, Oral Solution, and Orally Disintegrating Strips) is a high-dose therapeutic vitamin D3 replenishment therapy on the WHO Model List of Essential Medicines. In the liver, it is converted to 25-hydroxyvitamin D3 (calcifediol), then in the kidneys to active 1,25-dihydroxyvitamin D3 (calcitriol). Calcitriol activates the nuclear Vitamin D Receptor (VDR), powerfully increasing intestinal absorption of dietary calcium and phosphorus by >30-40%, suppressing parathyroid hormone (PTH) secretion, and promoting bone mineralization. Indicated for treatment and prevention of clinical vitamin D deficiency, nutritional rickets, osteomalacia, postmenopausal osteoporosis, and secondary hyperparathyroidism.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Oral Iron and Folic Acid Formulations (Ferrous Ascorbate 100mg, Carbonyl Iron 50mg/100mg, Ferrous Asparto Glycinate with Folic Acid 1.5mg, L-Methylfolate, Zinc, and Vitamin B12) is an evidence-based hematinic on the WHO Model List of Essential Medicines. Ferrous ascorbate combines synthetic ascorbic acid (vitamin C) with divalent iron (Fe2+), maintaining iron in its soluble, highly absorbable ferrous state across duodenal pH and dramatically enhancing bioavailability while minimizing gastric mucosal irritation. Carbonyl iron provides ultra-pure elemental iron with delayed gastric acid dissolution, virtually eliminating nausea and toxicity. Folic acid and B12 support DNA synthesis and normoblastic erythropoiesis. Indicated for prevention and treatment of iron deficiency anemia, nutritional deficiency in pregnancy and lactation, and chronic menorrhagia.

Cholecalciferol (Vitamin D3 60,000 IU Softgels, Chewable Tablets, Granules Sachet, Oral Solution, and Orally Disintegrating Strips) is a high-dose therapeutic vitamin D3 replenishment therapy on the WHO Model List of Essential Medicines. In the liver, it is converted to 25-hydroxyvitamin D3 (calcifediol), then in the kidneys to active 1,25-dihydroxyvitamin D3 (calcitriol). Calcitriol activates the nuclear Vitamin D Receptor (VDR), powerfully increasing intestinal absorption of dietary calcium and phosphorus by >30-40%, suppressing parathyroid hormone (PTH) secretion, and promoting bone mineralization. Indicated for treatment and prevention of clinical vitamin D deficiency, nutritional rickets, osteomalacia, postmenopausal osteoporosis, and secondary hyperparathyroidism.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Cholecalciferol (Vitamin D3 60,000 IU Softgels, Chewable Tablets, Granules Sachet, Oral Solution, and Orally Disintegrating Strips) is a high-dose therapeutic vitamin D3 replenishment therapy on the WHO Model List of Essential Medicines. In the liver, it is converted to 25-hydroxyvitamin D3 (calcifediol), then in the kidneys to active 1,25-dihydroxyvitamin D3 (calcitriol). Calcitriol activates the nuclear Vitamin D Receptor (VDR), powerfully increasing intestinal absorption of dietary calcium and phosphorus by >30-40%, suppressing parathyroid hormone (PTH) secretion, and promoting bone mineralization. Indicated for treatment and prevention of clinical vitamin D deficiency, nutritional rickets, osteomalacia, postmenopausal osteoporosis, and secondary hyperparathyroidism.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Para Aminobenzoic Acid100mg, Calcium Pant 100mg, Niacinamide12mg, L-Arginine50mg L-Cysteine50mg, DL-Methionine40mg, L-Lysine20mg, Zinc25mg, Inositol 10mg, Biotin10mg, Ferrous10mg, Copper2mg Tablets is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Calcitriol Capsules (0.25mcg; alone or in bone complexes with Calcium, Vitamin K2-7, Zinc) is the biologically active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol) on the WHO Model List of Essential Medicines. Unlike cholecalciferol, it requires no metabolic activation by the liver or kidneys, directly activating intestinal calcium absorption and bone remodeling. Indicated for management of hypocalcemia and renal osteodystrophy in patients with chronic kidney disease, hypoparathyroidism, pseudohypoparathyroidism, and severe osteoporosis.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Calcium Formulations (Calcium Carbonate 500mg/1250mg, Calcium Citrate Malate 250mg/1000mg, Coral Calcium with Vitamin D3 250-2000 IU, Vitamin K2-7, Magnesium, and Zinc) is an oral bone remineralization complex on the WHO Model List of Essential Medicines. Calcium provides elemental bone mineral matrix; vitamin D3 stimulates intestinal calcium transport; vitamin K2-7 (menaquinone-7) activates osteocalcin to bind calcium into hydroxyapatite crystals while preventing ectopic arterial vascular calcification; zinc and magnesium act as essential osteoblast cofactors. Indicated for prevention and treatment of postmenopausal osteoporosis, osteopenia, pregnancy/lactation calcium demands, and bone fracture healing.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.

Calcitriol Capsules (0.25mcg; alone or in bone complexes with Calcium, Vitamin K2-7, Zinc) is the biologically active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol) on the WHO Model List of Essential Medicines. Unlike cholecalciferol, it requires no metabolic activation by the liver or kidneys, directly activating intestinal calcium absorption and bone remodeling. Indicated for management of hypocalcemia and renal osteodystrophy in patients with chronic kidney disease, hypoparathyroidism, pseudohypoparathyroidism, and severe osteoporosis.

Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.